Cetuximab β；Fruquintinib；
concept
Phase 2 small_molecule active
Quick answer
Cetuximab β；Fruquintinib； for Colorectal Neoplasms is a Phase 2 program (small_molecule) at Zhejiang University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zhejiang University
- Indication
- Colorectal Neoplasms
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active